Lexeo Therapeutics Stock Quote LXEO - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

11.77

Bid

11.60

Ask

11.98

Volume

504,475

11.21 Day's Range 12.33

9.00 52 Week Range 22.33

Market Cap

387.767M

Previous Close

11.54

Open

11.21

Last Trade

11.77

Last Trade Time

Financial Volume

$ 5,945,750

VWAP

11.786

Average Volume (3m)

265,574

Shares Outstanding

32,945,341

Dividend Yield

PE Ratio

-5.84

Earnings Per Share (EPS)

-2.02

Revenue

Net Profit

-66.39M

Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene t... Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.lexeotx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Lexeo Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker LXEO. The last closing price for Lexeo Therapeutics was $11.54. Over the last year, Lexeo Therapeutics shares have traded in a share price range of $ 9.00 to $ 22.33.

Lexeo Therapeutics currently has 32,945,341 shares outstanding. The market capitalization of Lexeo Therapeutics is $380.19 million. Lexeo Therapeutics has a price to earnings ratio (PE ratio) of -5.84.

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy

Achieved mean reduction in left ventricular mass index (LVMI) of 11.4% at 12 months and 18.3% at 18 months in participants with elevated LVMI at baseline >10% reduction in LVMI at 12 months in...

Form 4 - Statement of changes in beneficial ownership of securities

Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy on Monday, July 15, 2024

NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.54	-11.5702479339	13.31	13.48	10.9	396492	11.6515024	CS
4	-5.21	-30.6831566549	16.98	19.5	10.9	465816	14.34046019	CS
12	-0.46	-3.76124284546	12.23	19.5	10.9	265574	15.008473	CS
26	-5.13	-30.3550295858	16.9	19.5	10.9	179085	14.91877501	CS
52	2.27	23.8947368421	9.5	22.33	9	166765	14.40136523	CS
156	2.27	23.8947368421	9.5	22.33	9	166765	14.40136523	CS
260	2.27	23.8947368421	9.5	22.33	9	166765	14.40136523	CS

Symbol	Price	Vol.
DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF	20.10 (839.25%)	128.82k
RGCRegencell Bioscience Holdings Ltd	$ 15.15 (349.55%)	1.34M
ATPCAgape ATP Corporation	$ 0.2262 (58.18%)	107.32M
SLRXSalarius Pharmaceuticals Inc	$ 2.34 (51.95%)	60.04M
GSUNGolden Sun Health Technology Group Ltd	$ 7.46 (45.42%)	590.09k
FLYEFly E Group Inc	$ 1.1601 (-81.82%)	25.44M
RNAZTransCode Therapeutics Inc	$ 0.3035 (-61.70%)	9.78M
JAGXJaguar Health Inc	$ 1.755 (-58.90%)	15.47M
MIRAMIRA Pharmaceuticals Inc	$ 2.55 (-49.10%)	25.64M
IVPInspire Veterinary Partners Inc	$ 5.19 (-43.83%)	1.67M
SLNASelina Hospitality PLC	$ 0.026 (-29.73%)	220.33M
SPWRSunPower Corporation	$ 0.9514 (32.91%)	186.76M
NVDANVIDIA Corporation	$ 122.59 (-0.77%)	173.91M
ADILAdial Pharmaceuticals Inc	$ 1.3422 (26.62%)	160.04M
HOLOMicroCloud Hologram Inc	$ 0.588 (26.07%)	135.56M

Symbol

Price

Vol.